APO Research
Talk to an analyst

APO RESEARCH · REPORT

Autologous Immune Cell Storage

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Autologous Immune Cell Storage Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 May 2026193 pages

Choose your research edition.

Industry ResearchAutologous Immune Cell Storage Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Autologous Immune Cell Storage Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Autologous Immune Cell Storage Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Autologous Immune Cell Storage Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Autologous Immune Cell Storage Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global Autologous Immune Cell Storage market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Autologous Immune Cell Storage is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Autologous Immune Cell Storage is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Autologous Immune Cell Storage is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Autologous Immune Cell Storage is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Autologous Immune Cell Storage include HealthBanks, Aeterna Health, Cell Vault, Redermis, Innovita Research, STEMCELL, Enhance Biomedical, Immunaeon and Miracell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Autologous Immune Cell Storage market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Autologous Immune Cell Storage and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Autologous Immune Cell Storage revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Autologous Immune Cell Storage market size, projected growth trends, production technologies, key applications, and end-use industries.

Autologous Immune Cell Storage Segment by Company

HealthBanks

Aeterna Health

Cell Vault

Redermis

Innovita Research

STEMCELL

Enhance Biomedical

Immunaeon

Miracell

VCANBIO Cell and Gene Engineering Corp., Ltd.

Shenzhen Beike Bio-Technology Co.,Ltd

Beijing Health and Biotech Group Corp. Ltd.

Shanghai Cell Therapy Group Co. Ltd.

BGI Genomics

Shanghai Saiyao Biotechnology Co., Ltd.

Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.

Autologous Immune Cell Storage Segment by Type

Lymphocyte Storage

Hematopoietic Stem Cell Storage

Autologous Immune Cell Storage Segment by Application

Treat Leukemia and Blood-Related Diseases

Immune System Modulation

Stem Cell Transplant

Autologous Immune Cell Storage Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autologous Immune Cell Storage market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autologous Immune Cell Storage and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autologous Immune Cell Storage.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Autologous Immune Cell Storage in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Autologous Immune Cell Storage industry.

Chapter 3: Detailed analysis of Autologous Immune Cell Storage companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Autologous Immune Cell Storagerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Autologous Immune Cell Storage Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Lymphocyte Storage Table 3. Key Players of Hematopoietic Stem Cell Storage Table 4. Global Autologous Immune Cell Storage Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Treat Leukemia and Blood-Related Diseases Table 6. Key Players of Immune System Modulation Table 7. Key Players of Stem Cell Transplant Table 8. Global Autologous Immune Cell Storage Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Autologous Immune Cell Storage Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Autologous Immune Cell Storage Market Share by Region (2021-2026) Table 11. Global Autologous Immune Cell Storage Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Autologous Immune Cell Storage Market Share by Region (2027-2032) Table 13. Autologous Immune Cell Storage Industry Trends Table 14. Autologous Immune Cell Storage Industry Drivers Table 15. Autologous Immune Cell Storage Industry Opportunities and Challenges Table 16. Autologous Immune Cell Storage Industry Restraints Table 17. Global Autologous Immune Cell Storage Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Autologous Immune Cell Storage Revenue Market Share by Company (2021-2026) Table 19. Global Autologous Immune Cell Storage Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Autologous Immune Cell Storage Key Company Head Office and Area Served Table 21. Global Autologous Immune Cell Storage Company, Product Type & Application Table 22. Global Autologous Immune Cell Storage Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Autologous Immune Cell Storage by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Autologous Immune Cell Storage Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Autologous Immune Cell Storage Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Autologous Immune Cell Storage Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Autologous Immune Cell Storage Revenue Market Share by Type (2021-2026) Table 29. Global Autologous Immune Cell Storage Revenue Market Share by Type (2027-2032) Table 30. Global Autologous Immune Cell Storage Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Autologous Immune Cell Storage Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Autologous Immune Cell Storage Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Autologous Immune Cell Storage Revenue Market Share by Application (2021-2026) Table 34. Global Autologous Immune Cell Storage Revenue Market Share by Application (2027-2032) Table 35. HealthBanks Company Information Table 36. HealthBanks Business Overview Table 37. HealthBanks Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. HealthBanks Autologous Immune Cell Storage Product Portfolio Table 39. HealthBanks Recent Development Table 40. Aeterna Health Company Information Table 41. Aeterna Health Business Overview Table 42. Aeterna Health Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Aeterna Health Autologous Immune Cell Storage Product Portfolio Table 44. Aeterna Health Recent Development Table 45. Cell Vault Company Information Table 46. Cell Vault Business Overview Table 47. Cell Vault Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Cell Vault Autologous Immune Cell Storage Product Portfolio Table 49. Cell Vault Recent Development Table 50. Redermis Company Information Table 51. Redermis Business Overview Table 52. Redermis Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Redermis Autologous Immune Cell Storage Product Portfolio Table 54. Redermis Recent Development Table 55. Innovita Research Company Information Table 56. Innovita Research Business Overview Table 57. Innovita Research Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Innovita Research Autologous Immune Cell Storage Product Portfolio Table 59. Innovita Research Recent Development Table 60. STEMCELL Company Information Table 61. STEMCELL Business Overview Table 62. STEMCELL Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. STEMCELL Autologous Immune Cell Storage Product Portfolio Table 64. STEMCELL Recent Development Table 65. Enhance Biomedical Company Information Table 66. Enhance Biomedical Business Overview Table 67. Enhance Biomedical Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Enhance Biomedical Autologous Immune Cell Storage Product Portfolio Table 69. Enhance Biomedical Recent Development Table 70. Immunaeon Company Information Table 71. Immunaeon Business Overview Table 72. Immunaeon Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Immunaeon Autologous Immune Cell Storage Product Portfolio Table 74. Immunaeon Recent Development Table 75. Miracell Company Information Table 76. Miracell Business Overview Table 77. Miracell Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Miracell Autologous Immune Cell Storage Product Portfolio Table 79. Miracell Recent Development Table 80. VCANBIO Cell and Gene Engineering Corp., Ltd. Company Information Table 81. VCANBIO Cell and Gene Engineering Corp., Ltd. Business Overview Table 82. VCANBIO Cell and Gene Engineering Corp., Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. VCANBIO Cell and Gene Engineering Corp., Ltd. Autologous Immune Cell Storage Product Portfolio Table 84. VCANBIO Cell and Gene Engineering Corp., Ltd. Recent Development Table 85. Shenzhen Beike Bio-Technology Co.,Ltd Company Information Table 86. Shenzhen Beike Bio-Technology Co.,Ltd Business Overview Table 87. Shenzhen Beike Bio-Technology Co.,Ltd Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Shenzhen Beike Bio-Technology Co.,Ltd Autologous Immune Cell Storage Product Portfolio Table 89. Shenzhen Beike Bio-Technology Co.,Ltd Recent Development Table 90. Beijing Health and Biotech Group Corp. Ltd. Company Information Table 91. Beijing Health and Biotech Group Corp. Ltd. Business Overview Table 92. Beijing Health and Biotech Group Corp. Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Beijing Health and Biotech Group Corp. Ltd. Autologous Immune Cell Storage Product Portfolio Table 94. Beijing Health and Biotech Group Corp. Ltd. Recent Development Table 95. Shanghai Cell Therapy Group Co. Ltd. Company Information Table 96. Shanghai Cell Therapy Group Co. Ltd. Business Overview Table 97. Shanghai Cell Therapy Group Co. Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Shanghai Cell Therapy Group Co. Ltd. Autologous Immune Cell Storage Product Portfolio Table 99. Shanghai Cell Therapy Group Co. Ltd. Recent Development Table 100. BGI Genomics Company Information Table 101. BGI Genomics Business Overview Table 102. BGI Genomics Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. BGI Genomics Autologous Immune Cell Storage Product Portfolio Table 104. BGI Genomics Recent Development Table 105. Shanghai Saiyao Biotechnology Co., Ltd. Company Information Table 106. Shanghai Saiyao Biotechnology Co., Ltd. Business Overview Table 107. Shanghai Saiyao Biotechnology Co., Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Shanghai Saiyao Biotechnology Co., Ltd. Autologous Immune Cell Storage Product Portfolio Table 109. Shanghai Saiyao Biotechnology Co., Ltd. Recent Development Table 110. Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Company Information Table 111. Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Business Overview Table 112. Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Autologous Immune Cell Storage Product Portfolio Table 114. Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Recent Development Table 115. North America Autologous Immune Cell Storage Market Size by Type (2021-2026) & (US$ Million) Table 116. North America Autologous Immune Cell Storage Market Size by Type (2027-2032) & (US$ Million) Table 117. North America Autologous Immune Cell Storage Market Size by Application (2021-2026) & (US$ Million) Table 118. North America Autologous Immune Cell Storage Market Size by Application (2027-2032) & (US$ Million) Table 119. North America Autologous Immune Cell Storage Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Autologous Immune Cell Storage Market Size by Country (2021-2026) Table 121. North America Autologous Immune Cell Storage Market Size by Country (2027-2032) Table 122. Europe Autologous Immune Cell Storage Market Size by Type (2021-2026) & (US$ Million) Table 123. Europe Autologous Immune Cell Storage Market Size by Type (2027-2032) & (US$ Million) Table 124. Europe Autologous Immune Cell Storage Market Size by Application (2021-2026) & (US$ Million) Table 125. Europe Autologous Immune Cell Storage Market Size by Application (2027-2032) & (US$ Million) Table 126. Europe Autologous Immune Cell Storage Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Autologous Immune Cell Storage Market Size by Country (2021-2026) Table 128. Europe Autologous Immune Cell Storage Market Size by Country (2027-2032) Table 129. China Autologous Immune Cell Storage Market Size by Type (2021-2026) & (US$ Million) Table 130. China Autologous Immune Cell Storage Market Size by Type (2027-2032) & (US$ Million) Table 131. China Autologous Immune Cell Storage Market Size by Application (2021-2026) & (US$ Million) Table 132. China Autologous Immune Cell Storage Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia Autologous Immune Cell Storage Market Size by Type (2021-2026) & (US$ Million) Table 134. Asia Autologous Immune Cell Storage Market Size by Type (2027-2032) & (US$ Million) Table 135. Asia Autologous Immune Cell Storage Market Size by Application (2021-2026) & (US$ Million) Table 136. Asia Autologous Immune Cell Storage Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia Autologous Immune Cell Storage Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia Autologous Immune Cell Storage Market Size by Country (2021-2026) Table 139. Asia Autologous Immune Cell Storage Market Size by Country (2027-2032) Table 140. South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Type (2021-2026) & (US$ Million) Table 141. South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Type (2027-2032) & (US$ Million) Table 142. South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Application (2021-2026) & (US$ Million) Table 143. South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Application (2027-2032) & (US$ Million) Table 144. South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Country (2021-2026) Table 146. South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Country (2027-2032) Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Autologous Immune Cell Storage Product Image Figure 2. Global Autologous Immune Cell Storage Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Autologous Immune Cell Storage Market Share by Type: 2025 VS 2032 Figure 4. Lymphocyte Storage Image Figure 5. Hematopoietic Stem Cell Storage Image Figure 6. Global Autologous Immune Cell Storage Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Autologous Immune Cell Storage Market Share by Application: 2025 VS 2032 Figure 8. Treat Leukemia and Blood-Related Diseases Image Figure 9. Immune System Modulation Image Figure 10. Stem Cell Transplant Image Figure 11. Global Autologous Immune Cell Storage Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 13. Global Autologous Immune Cell Storage Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Autologous Immune Cell Storage Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Autologous Immune Cell Storage Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Autologous Immune Cell Storage Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Autologous Immune Cell Storage Revenue Market Share by Type (2021-2032) Figure 20. Global Autologous Immune Cell Storage Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Autologous Immune Cell Storage Revenue Market Share by Application (2021-2032) Figure 22. North America Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 23. North America Autologous Immune Cell Storage Market Share by Type (2021-2032) Figure 24. North America Autologous Immune Cell Storage Market Share by Application (2021-2032) Figure 25. North America Autologous Immune Cell Storage Market Share by Country (2021-2032) Figure 26. United States Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 27. Canada Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 29. Europe Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 30. Europe Autologous Immune Cell Storage Market Share by Type (2021-2032) Figure 31. Europe Autologous Immune Cell Storage Market Share by Application (2021-2032) Figure 32. Europe Autologous Immune Cell Storage Market Share by Country (2021-2032) Figure 33. Germany Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 34. France Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 36. Italy Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 37. Russia Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 39. China Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 40. China Autologous Immune Cell Storage Market Share by Type (2021-2032) Figure 41. China Autologous Immune Cell Storage Market Share by Application (2021-2032) Figure 42. Asia Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 43. Asia Autologous Immune Cell Storage Market Share by Type (2021-2032) Figure 44. Asia Autologous Immune Cell Storage Market Share by Application (2021-2032) Figure 45. Asia Autologous Immune Cell Storage Market Share by Country (2021-2032) Figure 46. Japan Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 50. India Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 51. Australia Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Autologous Immune Cell Storage Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Autologous Immune Cell Storage Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Autologous Immune Cell Storage Market Share by Country (2021-2032) Figure 56. Brazil Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 61. UAE Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 63. Chile Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Lymphocyte Storage
  • Hematopoietic Stem Cell Storage
Applications
  • Treat Leukemia and Blood-Related Diseases
  • Immune System Modulation
  • Stem Cell Transplant
Companies covered
  • HealthBanks
  • Aeterna Health
  • Cell Vault
  • Redermis
  • Innovita Research
  • STEMCELL
  • Enhance Biomedical
  • Immunaeon
  • Miracell
  • VCANBIO Cell and Gene Engineering Corp., Ltd.
  • Shenzhen Beike Bio-Technology Co.,Ltd
  • Beijing Health and Biotech Group Corp. Ltd.
  • Shanghai Cell Therapy Group Co. Ltd.
  • BGI Genomics
  • Shanghai Saiyao Biotechnology Co., Ltd.
  • Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Autologous Immune Cell Storage Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Lymphocyte Storage
  5. 1.2.3 Hematopoietic Stem Cell Storage
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Autologous Immune Cell Storage Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Treat Leukemia and Blood-Related Diseases
  9. 1.3.3 Immune System Modulation
  10. 1.3.4 Stem Cell Transplant
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Autologous Immune Cell Storage Growth Trends by Region
  13. 1.5.1 Global Autologous Immune Cell Storage Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Autologous Immune Cell Storage Market Size by Region (2021-2026)
  15. 1.5.3 Autologous Immune Cell Storage Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Autologous Immune Cell Storage Market Dynamics
  1. 2.1 Autologous Immune Cell Storage Industry Trends
  2. 2.2 Autologous Immune Cell Storage Industry Drivers
  3. 2.3 Autologous Immune Cell Storage Industry Opportunities and Challenges
  4. 2.4 Autologous Immune Cell Storage Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Autologous Immune Cell Storage Revenue by Company (2021-2026)
  2. 3.2 Global Autologous Immune Cell Storage Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Autologous Immune Cell Storage Key Company Head office and Area Served
  4. 3.4 Global Autologous Immune Cell Storage Company, Product Type & Application
  5. 3.5 Global Autologous Immune Cell Storage Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Autologous Immune Cell Storage Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Autologous Immune Cell Storage Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Autologous Immune Cell Storage Tier 1, Tier 2, and Tier 3
4 Autologous Immune Cell Storage Market by Type
  1. 4.1 Global Autologous Immune Cell Storage Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Autologous Immune Cell Storage Market Size by Type (2021-2032)
  3. 4.3 Global Autologous Immune Cell Storage Market Size Share by Type (2021-2032)
5 Autologous Immune Cell Storage Market by Application
  1. 5.1 Global Autologous Immune Cell Storage Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Autologous Immune Cell Storage Market Size by Application (2021-2032)
  3. 5.3 Global Autologous Immune Cell Storage Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 HealthBanks
  2. 6.1.1 HealthBanks Company Information
  3. 6.1.2 HealthBanks Business Overview
  4. 6.1.3 HealthBanks Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 HealthBanks Autologous Immune Cell Storage Product Portfolio
  6. 6.1.5 HealthBanks Recent Developments
  7. 6.2 Aeterna Health
  8. 6.2.1 Aeterna Health Company Information
  9. 6.2.2 Aeterna Health Business Overview
  10. 6.2.3 Aeterna Health Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Aeterna Health Autologous Immune Cell Storage Product Portfolio
  12. 6.2.5 Aeterna Health Recent Developments
  13. 6.3 Cell Vault
  14. 6.3.1 Cell Vault Company Information
  15. 6.3.2 Cell Vault Business Overview
  16. 6.3.3 Cell Vault Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Cell Vault Autologous Immune Cell Storage Product Portfolio
  18. 6.3.5 Cell Vault Recent Developments
  19. 6.4 Redermis
  20. 6.4.1 Redermis Company Information
  21. 6.4.2 Redermis Business Overview
  22. 6.4.3 Redermis Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Redermis Autologous Immune Cell Storage Product Portfolio
  24. 6.4.5 Redermis Recent Developments
  25. 6.5 Innovita Research
  26. 6.5.1 Innovita Research Company Information
  27. 6.5.2 Innovita Research Business Overview
  28. 6.5.3 Innovita Research Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Innovita Research Autologous Immune Cell Storage Product Portfolio
  30. 6.5.5 Innovita Research Recent Developments
  31. 6.6 STEMCELL
  32. 6.6.1 STEMCELL Company Information
  33. 6.6.2 STEMCELL Business Overview
  34. 6.6.3 STEMCELL Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 STEMCELL Autologous Immune Cell Storage Product Portfolio
  36. 6.6.5 STEMCELL Recent Developments
  37. 6.7 Enhance Biomedical
  38. 6.7.1 Enhance Biomedical Company Information
  39. 6.7.2 Enhance Biomedical Business Overview
  40. 6.7.3 Enhance Biomedical Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Enhance Biomedical Autologous Immune Cell Storage Product Portfolio
  42. 6.7.5 Enhance Biomedical Recent Developments
  43. 6.8 Immunaeon
  44. 6.8.1 Immunaeon Company Information
  45. 6.8.2 Immunaeon Business Overview
  46. 6.8.3 Immunaeon Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Immunaeon Autologous Immune Cell Storage Product Portfolio
  48. 6.8.5 Immunaeon Recent Developments
  49. 6.9 Miracell
  50. 6.9.1 Miracell Company Information
  51. 6.9.2 Miracell Business Overview
  52. 6.9.3 Miracell Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Miracell Autologous Immune Cell Storage Product Portfolio
  54. 6.9.5 Miracell Recent Developments
  55. 6.10 VCANBIO Cell and Gene Engineering Corp., Ltd.
  56. 6.10.1 VCANBIO Cell and Gene Engineering Corp., Ltd. Company Information
  57. 6.10.2 VCANBIO Cell and Gene Engineering Corp., Ltd. Business Overview
  58. 6.10.3 VCANBIO Cell and Gene Engineering Corp., Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 VCANBIO Cell and Gene Engineering Corp., Ltd. Autologous Immune Cell Storage Product Portfolio
  60. 6.10.5 VCANBIO Cell and Gene Engineering Corp., Ltd. Recent Developments
  61. 6.11 Shenzhen Beike Bio-Technology Co.,Ltd
  62. 6.11.1 Shenzhen Beike Bio-Technology Co.,Ltd Company Information
  63. 6.11.2 Shenzhen Beike Bio-Technology Co.,Ltd Business Overview
  64. 6.11.3 Shenzhen Beike Bio-Technology Co.,Ltd Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Shenzhen Beike Bio-Technology Co.,Ltd Autologous Immune Cell Storage Product Portfolio
  66. 6.11.5 Shenzhen Beike Bio-Technology Co.,Ltd Recent Developments
  67. 6.12 Beijing Health and Biotech Group Corp. Ltd.
  68. 6.12.1 Beijing Health and Biotech Group Corp. Ltd. Company Information
  69. 6.12.2 Beijing Health and Biotech Group Corp. Ltd. Business Overview
  70. 6.12.3 Beijing Health and Biotech Group Corp. Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Beijing Health and Biotech Group Corp. Ltd. Autologous Immune Cell Storage Product Portfolio
  72. 6.12.5 Beijing Health and Biotech Group Corp. Ltd. Recent Developments
  73. 6.13 Shanghai Cell Therapy Group Co. Ltd.
  74. 6.13.1 Shanghai Cell Therapy Group Co. Ltd. Company Information
  75. 6.13.2 Shanghai Cell Therapy Group Co. Ltd. Business Overview
  76. 6.13.3 Shanghai Cell Therapy Group Co. Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Shanghai Cell Therapy Group Co. Ltd. Autologous Immune Cell Storage Product Portfolio
  78. 6.13.5 Shanghai Cell Therapy Group Co. Ltd. Recent Developments
  79. 6.14 BGI Genomics
  80. 6.14.1 BGI Genomics Company Information
  81. 6.14.2 BGI Genomics Business Overview
  82. 6.14.3 BGI Genomics Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 BGI Genomics Autologous Immune Cell Storage Product Portfolio
  84. 6.14.5 BGI Genomics Recent Developments
  85. 6.15 Shanghai Saiyao Biotechnology Co., Ltd.
  86. 6.15.1 Shanghai Saiyao Biotechnology Co., Ltd. Company Information
  87. 6.15.2 Shanghai Saiyao Biotechnology Co., Ltd. Business Overview
  88. 6.15.3 Shanghai Saiyao Biotechnology Co., Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Shanghai Saiyao Biotechnology Co., Ltd. Autologous Immune Cell Storage Product Portfolio
  90. 6.15.5 Shanghai Saiyao Biotechnology Co., Ltd. Recent Developments
  91. 6.16 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.
  92. 6.16.1 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Company Information
  93. 6.16.2 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Business Overview
  94. 6.16.3 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Autologous Immune Cell Storage Product Portfolio
  96. 6.16.5 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Recent Developments
7 North America
  1. 7.1 North America Autologous Immune Cell Storage Market Size (2021-2032)
  2. 7.2 North America Autologous Immune Cell Storage Market Size by Type
  3. 7.2.1 North America Autologous Immune Cell Storage Market Size by Type (2021-2026)
  4. 7.2.2 North America Autologous Immune Cell Storage Market Size by Type (2027-2032)
  5. 7.2.3 North America Autologous Immune Cell Storage Market Share by Type (2021-2032)
  6. 7.3 North America Autologous Immune Cell Storage Market Size by Application
  7. 7.3.1 North America Autologous Immune Cell Storage Market Size by Application (2021-2026)
  8. 7.3.2 North America Autologous Immune Cell Storage Market Size by Application (2027-2032)
  9. 7.3.3 North America Autologous Immune Cell Storage Market Share by Application (2021-2032)
  10. 7.4 North America Autologous Immune Cell Storage Market Size by Country
  11. 7.4.1 North America Autologous Immune Cell Storage Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Autologous Immune Cell Storage Market Size by Country (2021-2026)
  13. 7.4.3 North America Autologous Immune Cell Storage Market Size by Country (2027-2032)
  14. 7.4.4 North America Autologous Immune Cell Storage Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Autologous Immune Cell Storage Market Size (2021-2032)
  2. 8.2 Europe Autologous Immune Cell Storage Market Size by Type
  3. 8.2.1 Europe Autologous Immune Cell Storage Market Size by Type (2021-2026)
  4. 8.2.2 Europe Autologous Immune Cell Storage Market Size by Type (2027-2032)
  5. 8.2.3 Europe Autologous Immune Cell Storage Market Share by Type (2021-2032)
  6. 8.3 Europe Autologous Immune Cell Storage Market Size by Application
  7. 8.3.1 Europe Autologous Immune Cell Storage Market Size by Application (2021-2026)
  8. 8.3.2 Europe Autologous Immune Cell Storage Market Size by Application (2027-2032)
  9. 8.3.3 Europe Autologous Immune Cell Storage Market Share by Application (2021-2032)
  10. 8.4 Europe Autologous Immune Cell Storage Market Size by Country
  11. 8.4.1 Europe Autologous Immune Cell Storage Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Autologous Immune Cell Storage Market Size by Country (2021-2026)
  13. 8.4.3 Europe Autologous Immune Cell Storage Market Size by Country (2027-2032)
  14. 8.4.4 Europe Autologous Immune Cell Storage Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Autologous Immune Cell Storage Market Size (2021-2032)
  2. 9.2 China Autologous Immune Cell Storage Market Size by Type
  3. 9.2.1 China Autologous Immune Cell Storage Market Size by Type (2021-2026)
  4. 9.2.2 China Autologous Immune Cell Storage Market Size by Type (2027-2032)
  5. 9.2.3 China Autologous Immune Cell Storage Market Share by Type (2021-2032)
  6. 9.3 China Autologous Immune Cell Storage Market Size by Application
  7. 9.3.1 China Autologous Immune Cell Storage Market Size by Application (2021-2026)
  8. 9.3.2 China Autologous Immune Cell Storage Market Size by Application (2027-2032)
  9. 9.3.3 China Autologous Immune Cell Storage Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Autologous Immune Cell Storage Market Size (2021-2032)
  2. 10.2 Asia Autologous Immune Cell Storage Market Size by Type
  3. 10.2.1 Asia Autologous Immune Cell Storage Market Size by Type (2021-2026)
  4. 10.2.2 Asia Autologous Immune Cell Storage Market Size by Type (2027-2032)
  5. 10.2.3 Asia Autologous Immune Cell Storage Market Share by Type (2021-2032)
  6. 10.3 Asia Autologous Immune Cell Storage Market Size by Application
  7. 10.3.1 Asia Autologous Immune Cell Storage Market Size by Application (2021-2026)
  8. 10.3.2 Asia Autologous Immune Cell Storage Market Size by Application (2027-2032)
  9. 10.3.3 Asia Autologous Immune Cell Storage Market Share by Application (2021-2032)
  10. 10.4 Asia Autologous Immune Cell Storage Market Size by Country
  11. 10.4.1 Asia Autologous Immune Cell Storage Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Autologous Immune Cell Storage Market Size by Country (2021-2026)
  13. 10.4.3 Asia Autologous Immune Cell Storage Market Size by Country (2027-2032)
  14. 10.4.4 Asia Autologous Immune Cell Storage Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Autologous Immune Cell Storage Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Autologous Immune Cell Storage Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Autologous Immune Cell Storage Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Autologous Immune Cell Storage Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Autologous Immune Cell Storage Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst